Results 1 to 10 of about 926 (210)

Pregnancy outcomes after inadvertent exposure of anti-obesity drugs during pregnancy

Clinical and Experimental Obstetrics & Gynecology, 2021
Backgrounds: To improve health, an increasing number of adults are attempting to lose weight. Moreover, the number of childbearing women targeting weight loss has increased, with a surge in pregnant women exposed to anti-obesity drugs.
Eun Jeong Choi, Jung Yeol Han
doaj   +3 more sources

Polypharmacotherapy with anti-obesity drugs - case report

Journal of Education, Health and Sport, 2022
Obesity is a chronic, relapsing, multi-factorial, neurobehavioral disease, wherein an increase in body fat promotes adipose tissue dysfunction and abnormal fat mass physical forces, resulting in adverse health consequences. It is diagnosed based on body
Jakub Gołacki, Aleksandra Marczak, Michalina Hordejuk, Klaudia Sapuła, Klaudyna Iwaszko-Sochal   +4 more
doaj   +2 more sources

Anti-obesity drugs: past, present and future [PDF]

Disease Models & Mechanisms, 2012
The ideal anti-obesity drug would produce sustained weight loss with minimal side effects. The mechanisms that regulate energy balance have substantial built-in redundancy, overlap considerably with other physiological functions, and are influenced by ...
R. John Rodgers, Matthias H. Tschöp, John P. H. Wilding   +2 more
doaj   +3 more sources

Do we need anti‐obesity drugs? [PDF]

Diabetes/Metabolism Research and Reviews, 2012
SummaryThe increasing global prevalence of obesity urgently requires an implementation of efficient preventive and therapeutic measures. Weight loss and its maintenance should be considered one of the most important strategies to reduce the incidence of obesity‐related co‐morbidities such as diabetes and cardiovascular diseases.
Vojtěch, Hainer, Irena Aldhoon, Hainerová   +1 more
exaly   +3 more sources

Analysis of Reporting Trends of Serious Adverse Events Associated With Anti‐Obesity Drugs

Pharmacology Research & Perspectives
Concern over the side effects of anti‐obesity medications, particularly if severe, has grown as their use has increased. Thus, the objective was to use trends in the reporting of suspected adverse events associated with anti‐obesity medications that have
Branislava B. Raičević, Andrej Belančić, Nikola Mirković, Slobodan M. Janković   +3 more
doaj   +2 more sources

Anti-Diabetic Drugs Inhibit Bulimia Induced Obesity

Frontiers in Bioscience-Landmark, 2023
Background: Obesity is primarily a consequence of food addiction. Drugs have been confirmed effective for weight loss more or less related to the functional connectivity in neural networks and metabolic patterns.
Zhu Li, Jia Jia, Han Hao, Shiyang Qiao, Qinglei Zhang, Xinlin Zhang, Yu Qi, Xuan Sun, Kun Wang, Rong Gu, Lina Kang, Biao Xu   +11 more
doaj   +1 more source

Anti-obesity drug discovery: advances and challenges [PDF]

Nature Reviews Drug Discovery, 2021
Enormous progress has been made in the last half-century in the management of diseases closely integrated with excess body weight, such as hypertension, adult-onset diabetes and elevated cholesterol. However, the treatment of obesity itself has proven largely resistant to therapy, with anti-obesity medications (AOMs) often delivering insufficient ...
Timo D. Müller, Matthias Blüher, Matthias H. Tschöp, Richard D. DiMarchi   +3 more
openaire   +3 more sources

Effect of Panax notoginseng Saponins and Major Anti-Obesity Components on Weight Loss

Frontiers in Pharmacology, 2021
The prevalence of individuals who are overweight or obese is rising rapidly globally. Currently, majority of drugs used to treat obesity are ineffective or are accompanied by obvious side effects; hence, the options are very limited.
Xuelian Zhang, Xuelian Zhang, Xuelian Zhang, Xuelian Zhang, Bin Zhang, Bin Zhang, Bin Zhang, Bin Zhang, Chenyang Zhang, Chenyang Zhang, Chenyang Zhang, Chenyang Zhang, Guibo Sun, Guibo Sun, Guibo Sun, Guibo Sun, Xiaobo Sun, Xiaobo Sun, Xiaobo Sun, Xiaobo Sun   +19 more
doaj   +1 more source

Lorcaserin and phentermine exert anti-obesity effects with modulation of the gut microbiota

Frontiers in Microbiology, 2023
Although drugs have been reported to modulate the gut microbiota, the effects of anti-obesity drugs on the gut microbiota remain unclear. Lorcaserin (LS) and phentermine (PT) are commonly used anti-obesity drugs.
Eun-Ji Song, Na Rae Shin, Songhee Jeon, Young-Do Nam, Hojun Kim   +4 more
doaj   +1 more source

Adolescent experiences of anti‐obesity drugs [PDF]

Clinical Obesity, 2015
SummaryOnly two anti‐obesity drugs (AODs) are frequently prescribed in paediatric obesity, orlistat and metformin. Meta‐analyses show modest benefit in clinical trials, yet analyses of prescribing databases show high levels of discontinuation in routine clinical practice.
White, Billy, Jamieson, L, Clifford, S, Hamilton-Shield, Julian P, Christie, D, Smith, F, Wong, Ian C. K., Viner, R M   +7 more
openaire   +4 more sources